Melanocortin-1 receptor structure and functional regulation

Pigment Cell Research

Volumn 18, Issue 6, 2005, Pages 393-410

  García Borrón, José C ^a   Sánchez Laorden, Berta L ^a   Jiménez Cervantes, Celia ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

G protein coupled receptor; Melanocortin; Melanocortin receptor; Melanocyte; Pigmentation; Polymorphism

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MELANOCORTIN 1 RECEPTOR;

CELL MEMBRANE; CELL STIMULATION; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; GENE EXPRESSION; HUMAN; MELANOCYTE; MELANOGENESIS; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MELANOCYTES; MOLECULAR SEQUENCE DATA; RECEPTORS, MELANOCORTIN; SKIN PIGMENTATION;

EID: 28044450150     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2005.00278.x     Document Type: Review

References (172)

1. Abdel-Malek, Z.A., Scott, M.C., Furumura, M., Lamoreux, M.L., Ollmann, M., Barsh, G.S., and Hearing, V.J. (2001). The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J. Cell Sci. 114, 1019-1024.
2. Adachi, S., Morii, E., Kim, D., Ogihara, H., Jippo, T., Ito, A., Lee, Y.M., and Kitamura, Y. (2000). Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice. J. Immunol. 164, 855-860.
3. Adalsteinsson, S., Hersteinsson, P., and Gunnarsson, E. (1987). Fox colors in relation to colors in mice and sheep. J. Hered. 78, 235-237.
4. Adams, G., Olivier, G.W., Branch, S.K., Moss, S.H., Notarianni, L.J., and Pouton, C.W. (1993). Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells. Ann. N. Y. Acad. Sci. 680, 440-441.
5. Angers, S., Salahpour, A., and Bouvier, M. (2002). Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435.
6. Aoki, H., and Moro, O. (2002). Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci. 71, 2171-2179.
7. Baig, A.H., Swords, F.M., Noon, L.A., King, P.J., Hunyady, L., and Clark, A.J.L. (2001). Desensitization of the Y1 cell adrenocorticotropin receptor. Evidence for a restricted heterologous mechanism implying a role foe receptor-effector complexes. J. Biol. Chem. 276, 44792-44797.
8. Bastiaens, M.T., ter Huurne, J.A., Kielich, C., Gruis, N.A., Westendorp, R.G., Vermeer, B.J., and Bavinck, J.N. (2001). Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884-894.
9. Bataille, V. (2003). Genetic epidemiology of melanoma. Eur. J. Cancer 39, 1341-1347.
10. Beaumont, K.A., Newton, R.A., Smit, D.J., Helen, L.J., Stow, J.L., and Sturm, R.A. (2005). Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 74, 2145-2154.
11. Bennett, D.C., and Lamoreux, M.L. (2003). The color loci of mice - a genetic century. Pigment Cell Res. 76, 333-344.
12. Biebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T., and Gruters, A. (2003). Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52, 2984-2988.
13. Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T., and Schwarz, A. (2005). α-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 5795-5802.
14. Bolognia, J., Murray, M., and Pawelek, J. (1989). UVB-induced melanogenesis may be mediated through the MSH-receptor system. J. Invest. Dermatol. 92, 651-656.
15. Box, N.F., Wyeth, J.R., O'Gorman, L.E., Martin, N.G., and Sturm, R.A. (1997). Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 1891-1897.
16. Breitwieser, G.E. (2004). G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ. Res. 94, 17-27.
17. Bultman, S.J., Michaud, E.J., and Woychik, R.P. (1992). Molecular characterization of the mouse agouti locus. Cell 71, 1195-1204.
18. Busca, R., and Ballotti, R. (2000). Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60-69.
19. Chakraborty, A.K., Orlow, S.J., Bolognia, J.L., and Pawelek, J.M. (1991). Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J. Cell. Physiol. 147, 1-6.
20. Chakraborty, A.K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J.M., and Ichihashi, M. (1996). Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130-138.
21. Chakraborty, A.K., Funasaka, Y., Pawelek, J.M., Nagahama, M., Ito, A., and Ichihashi, M. (1999). Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J. Invest. Dermatol. 112, 853-860.
22. Chen, G., Way, J., Armour, S., Watson, C., Queen, K., Jayawickreme, C.K., Chen, W.J., and Kenakin, T. (2000). Use of constitutive G protein-coupled receptor activity for drug discovery. Mol. Pharmacol. 57, 125-134.
23. Chhajlani, V., and Wikberg, J.E. (1992). Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417-420.
24. Chhajlani, V., Xu, X., Blauw, J., and Sudarshi, S. (1996). Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 219, 521-525.
25. Chluba-de Tapia, J., Bagutti, C., Cotti, R., and Eberle, A.N. (1996). Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J. Cell Sci. 109 (Pt 8), 2023-2030.
26. Cone, R.D., Lu, D., Koppula, S., Vage, D.I., Klungland, H., Boston, B., Chen, W., Orth, D.N., Pouton, C., and Kesterson, R.A. (1996). The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Norm. Res. 51, 287-317.
27. Conklin, B.R., and Bourne, H.R. (1993). Mouse coat colour reconsidered. Nature 364, 110.
28. Corre, S., Primot, A., Sviderskaya, E., Bennett, D.C., Vaulont, S., Goding, C.R., and Galibert, M.D. (2004). UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J. Biol. Chem. 279, 51226-51233.
29. Donatien, P.D., Hunt, G., Pieron, C., Lunec, J., Taieb, A., and Thody, A.J. (1992). The expression of functional MSH receptors on cultured human melanocytes. Arch. Dermatol. Res. 284, 424-426.
30. Duffy, D.L., Box, N.F., Chen, W., Palmer, J.S., Montgomery, G.W., James, M.R., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2004). Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum. Mol. Genet. 13, 447-461.
31. Elliott, R.J., Szabo, M., Wagner, M.J., Kemp, E.H., MacNeil, S., and Haycock, J.W. (2004). alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J. Invest. Dermatol. 122, 1010-1019.
32. Ermak, G., and Slominski, A. (1997). Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J. Invest. Dermatol. 108, 160-165.
33. Eves, P., Haycock, J., Layton, C. et al. (2003). Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br. J. Cancer 89, 2004-2015.
34. Fargnoli, M.C., Chimenti, S., Keller, G., Hofler, H., and Peris, K. (2003). Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum. Mutat. 21, 655.
35. Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (1998). Human pigmentation phenotype: a point mutation generates non-functional MSH receptor. Biochem. Biophys. Res. Commun. 245, 490-492.
36. Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (2001). Cysteine residues are involved in structure and function of melanocortin 1 receptor: substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Biochem. Biophys. Res. Commun. 281, 851-857.
37. Funasaka, Y., Chakraborty, A.K., Hayashi, Y., Komoto, M., Ohashi, A., Nagahama, M., Inoue, Y., Pawelek, J., and Ichihashi, M. (1998). Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1 alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br. J. Dermatol. 139, 216-224.
38. Gantz, I., and Fong, T.M. (2003). The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284, E468-E474.
39. Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J., and Yamada, T. (1993a). Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246-8250.
40. Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S.J., DelValle, J., and Yamada, T. (1993b). Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268, 15174-15179.
41. Garg, A.K., and Aggarwal, B.B. (2002). Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39, 509-517.
42. Geschwind, I.I. (1966). Change in hair color in mice induced by injection of alpha-MSH. Endocrinology 79, 1165-1167.
43. Gether, U. (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90-113.
44. Ghanem, G.E., Comunale, G., Libert, A., Vercammen, G., and Lejeune, F.J. (1988). Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells. Int. J. Cancer 41, 248-255.
45. Graham, A., Wakamatsu, K., Hunt, G., Ito, S., and Thody, A.J. (1997). Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. Pigment Cell Res. 10, 298-303.
46. Harding, R.M., Healy, E., Ray, A.J. et al. (2000). Evidence for variable selective pressures at MC1R. Am. J. Hum. Genet. 66, 1351-1361.
47. Haskell-Luevano, C., Sawyer, T.K., Trumpp-Kallmeyer, S., Bikker, J.A., Humblet, C., Gantz, I., and Hruby, V.J. (1996). Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des. Discov. 14, 197-211.
48. Healy, E. (2004). Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol. Photoimmunol. Photomed. 20, 283-288.
49. Healy, E., Flannagan, N., Ray, A., Todd, C., Jackson, I.J., Matthews, J.N., Birch-Machin, M.A., and Rees, J.L. (2000). Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 1072-1073.
50. Healy, E., Jordan, S.A., Budd, P.S., Suffolk, R., Rees, J.L., and Jackson, I.J. (2001). Functional variation of MC1R alleles from red-haired individuals. Hum. Mol. Genet. 10, 2397-2402.
51. Holder, J.R., and Haskell-Luevano, C. (2004). Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med. Res. Rev. 24, 325-356.
52. Holst, B., and Schwartz, T.W. (2003). Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann. N. Y. Acad. Sci. 994, 1-11.
53. Holst, B., Elling, C.E., and Schwartz, T.W. (2002). Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J. Biol. Chem. 277, 47662-47670.
54. Hoogduijn, M.J., McGurk, S., Smit, N.P., Nibbering, P.H., Ancans, J., van der Laarse, A., and Thody, A.J. (2002). Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem. Biophys. Res. Commun. 290, 844-850.
55. Hunt, G., and Thody, A.J. (1995). Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis. J. Endocrinol. 147, R1-R4.
56. Im, S., Moro, O., Peng, F., Medrano, E.E., Cornelius, J., Babcock, G., Nordlund, J.J., and Abdel-Malek, Z.A. (1998). Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res. 58, 47-54.
57. Ito, S. (2003). A chemist's view of melanogenesis. Pigment Cell Res. 16, 230-236.
58. Jimenez-Cervantes, C., Germer, S., Gonzalez, P., Sanchez, J., Sanchez, C.O., and Garcia-Borron, J.C. (2001a). Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett. 508, 44-48.
59. Jimenez-Cervantes, C., Martinez-Esparza, M., Perez, C., Daum, N., Solano, F., and Garcia-Borron, J.C. (2001b). Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J. Cell Sci. 114, 2335-2344.
60. Jimenez-Cervantes, C., Olivares, C., Gonzalez, P., Morandini, R., Ghanem, G., and Garcia-Borron, J.C. (2001c). The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J. Invest. Dermatol. 117, 156-158.
61. John, P.R., and Ramsay, M. (2002). Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S. Hum. Mutat. 19, 461-462.
62. John, P.R., Makova, K., Li, W.H., Jenkins, T., and Ramsay, M. (2003). DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals. Ann. N. Y. Acad. Sci. 994, 299-306.
63. Kadekaro, A.L., Kavanagh, R., Kanto, H. et al. (2005). α-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 4292-4299.
64. Kanetsky, P.A., Ge, F., Najarian, D., Swoyer, J., Panossian, S., Schuchter, L., Holmes, R., Guerry, D., and Rebbeck, T.R. (2004). Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol. Biomarkers Prev. 13, 808-819.
65. Kenakin, T. (2001). Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J. 15, 598-611.
66. Kiefer, L.L., Ittoop, O.R., Bunce, K., Truesdale, A.T., Willard, D.H., Nichols, J.S., Blanchard, S.G., Mountjoy, K., Chen, W.J., and Wilkinson, W.O. (1997). Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of lignad binding to the melanocortin receptors. Biochemistry 36, 2084-2090.
67. Kim, C.S., Lee, S.H., Kim, R.Y. et al. (2002). Identification of domains directing specificity of coupling to G-proteins for the melanocortin MC3 and MC4 receptors. J. Biol. Chem. 277, 31310-31317.
68. Klungland, H., Vage, D.I., Gomez-Raya, L., Adalsteinsson, S., and Lien, S. (1995). The role of melanocyte-stimulating hormone (MSH) receptor in bovine coat color determination. Mamm. Genome 6, 636-639.
69. Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994). Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166.
70. Koppula, S.V., Robbins, L.S., Lu, D., Baack, E., White, C.R. Jr, Swanson, N.A., and Cone, R.D. (1997). Identification of common polymorphisms in the coding sequence of the human MSH receptor (MC1R) with possible biological effects. Hum. Mutat. 9, 30-36.
71. Labbe, O., Desarnaud, F., Eggerickx, D., Vassart, G., and Parmentier, M. (1994). Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33, 4543-4549.
72. Leonard, J.H., Marks, L.H., Chen, W., Cook, A.L., Boyle, G.M., Smit, D.J., Brown, D.L., Stow, J.L., Parsons, P.G., and Sturm, R.A. (2003). Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies. Pigment Cell Res. 16, 198-207.
73. Lerner, A.B., and McGuire, J.S. (1961). Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man. Nature 189, 176-179.
74. Ling, M.K., Lagerstrom, M.C., Fredriksson, R., Okimoto, R., Mundy, N.I., Takeuchi, S., and Schioth, H.B. (2003). Association of feather colour with constitutively active melanocortin 1 receptors in chicken. Eur. J. Biochem. 270, 1441-1449.
75. Loir, B., Bouchard, B., Morandini, R., Del, M.V., Deraemaecker, R., Garcia-Borron, J.C., and Ghanem, G. (1997). Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells. Eur. J. Biochem. 244, 923-930.
76. Loir, B., Perez, S.C., Ghanem, G., Lozano, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (1999). Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cell. Mol. Biol. (Noisy-le-grand) 45, 1083-1092.
77. Lu, D., Willard, D., Patel, I.R. et al. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
78. Lu, D., Vage, D.I., and Cone, R.D. (1998a). A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol. Endocrinol. 12, 592-604.
79. Lu, D., Haskell-Luevano, C., Vage, D.I., and Cone, R.D. (1998b). Functional variants of the MSH receptor (MC1-R), agouti, and their effects on mammalian pigmentation. In G Proteins, Receptors, and Disease, A.M. Spiegel, ed. (Totowa, NJ: Humana Press), pp. 231-259.
80. Luttrell, L.M., and Lefkowitz, R.J. (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455-465.
81. Mandrika, I., Petrovska, R., and Wikberg, J. (2005). Melanocortin receptors form constitutive homo- and heterodimers. Biochem. Biophys. Res. Commun. 326, 349-354.
82. Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J.A., and Garcia-Borron, J.C. (1997). Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 3967-3972.
83. Martinez-Esparza, M., Jimenez-Cervantes, C., Solano, F., Lozano, J.A., and Garcia-Borron, J.C. (1998). Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells. Eur. J. Biochem. 255, 139-146.
84. Martinez-Esparza, M., Solano, F., and Garcia-Borron, J.C. (1999). Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell. Mol. Biol. (Noisy-le-grand) 45, 991-1000.
85. Martinez-Esparza, M., Ferrer, C., Castells, M.T., Garcia-Borron, J.C., and Zuasti, A. (2001). Transforming growth factor betal mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int. J. Biochem. Cell Biol. 33, 971-983.
86. Matichard, E., Verpillat, P., Meziani, R. et al. (2004). Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J. Med. Genet. 41, e13.
87. Miller, M.W., Duhl, D.M., Vrieling, H., Cordes, S.P., Ollmann, M.M., Winkes, B.M., and Barsh, G.S. (1993). Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7, 454-467.
88. Milligan, G. (2001). Oligomerisation of G-protein-coupled receptors. J. Cell Sci. 114, 1265-1271.
89. Minneman, K.P. (2001). Splice variants of G protein-coupled receptors. Mol. Interv. 1, 108-116.
90. Miserey-Lenkei, S., Parnot, C., Bardin, S., Corvol, P., and Clauser, E. (2002). Constitutive internalization of constitutively active angiotensin II AT1A receptor mutants is blocked by inverse agonists. J. Biol. Chem. 277, 5891-5901.
91. Moro, O., Ideta, R., and Ifuku, O. (1999). Characterization of the promoter region of the human melanocortin-1 receptor (MC1R) gene. Biochem. Biophys. Res. Commun. 262, 452-460.
92. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
93. Mountjoy, K.G., Kong, P.L., Taylor, J.A., Willard, D.H., and Wilkison, W.O. (2001). Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol. Genomics 5, 11-19.
94. Nappi, A.J., and Vass, E. (1996). Hydrogen peroxide generation associated with the oxidations of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Melanoma Res. 6, 341-349.
95. Newton, J.M., Wilkie, A.L., He, L., Jordan, S.A., Metallinos, D.L., Holmes, N.G., Jackson, I.J., and Barsh, G.S. (2000). Melanocortin 1 receptor variation in the domestic dog. Mamm. Genome 11, 24-30.
96. Ng, P.C., and Henikoff, S. (2001). Predicting deleterious amino acid substitutions. Genome Res. 11, 863-874.
97. Ng, P.C., and Henikoff, S. (2002). Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436-446.
98. Nijenhuis, W.A., Oosterom, J., and Adan, R.A. (2001). AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164-171.
99. Nishigori, C., Hattori, Y., and Toyokuni, S. (2004). Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal. 6, 561-570.
100. Ollmann, M.M., Lamoreux, M.L., Wilson, B.D., and Barsh, G.S. (1998). Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12, 316-330.
101. Palczewski, K., Kumasaka, T., Hori, T. et al. (2000). Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745.
102. Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O'Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176-186.
103. Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P., and Clauser, E. (2002). Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13, 336-343.
104. Pastorino, L., Cusano, R., Bruno, W., Lantieri, F., Origone, P., Barile, M., Gliori, S., Shepherd, G.A., Sturm, R.A., and Bianchi-Scarra, G. (2004). Novel MC1R variants in Ligurian melanoma patients and controls. Hum. Mutat. 24, 103.
105. Peng, S., Lu, X.M., Luo, H.R., Xiang-Yu, J.G., and Zhang, Y.P. (2001). Melanocortin-1 receptor gene variants in four Chinese ethnic populations. Cell Res. 11, 81-84.
106. Pitcher, J.A., Freedman, N.J., and Lefkowitz, R.J. (1998). G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653-692.
107. Prusis, P., Frandberg, P.A., Muceniece, R., Kalvinsh, I., and Wikberg, J.E. (1995). A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. Biochem. Biophys. Res. Commun. 210, 205-210.
108. Prusis, P., Schioth, H.B., Muceniece, R., Herzyk, P., Afshar, M., Hubbard, R.E., and Wikberg, J.E. (1997). Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J. Mol. Graph. Model. 15, 307-317, 334.
109. Qanbar, R., and Bouvier, M. (2003). Role of palmitoylation/ depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1-33.
110. Raffin-Sanson, M.L., de Keyzer, Y., and Bertagna, X. (2003). Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur. J. Endocrinol. 149, 79-90.
111. Rana, B.K., Hewett-Emmett, D., Jin, L. et al. (1999). High polymorphism at the human melanocortin 1 receptor locus. Genetics 151, 1547-1557.
112. Rees, J.L. (2003). Genetics of hair and skin color. Annu. Rev. Genet. 37, 67-90.
113. Ringholm, A., Klovins, J., Rudzish, R., Phillips, S., Rees, J.L., and Schioth, H.B. (2004). Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J. Invest. Dermatol. 123, 917-923.
114. Robbins, L.S., Nadeau, J.H., Johnson, K.R., Kelly, M.A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K.G., and Cone, R.D. (1993). Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834.
115. Robinson, S.J., and Healy, E. (2002). Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21, 8037-8046.
116. Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B., and Cone, R.D. (1993). Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl Acad. Sci. USA 90, 8856-8860.
117. Rouzaud, F., Annereau, J.P., Valencia, J.C., Costin, G.E., and Hearing, V.J. (2003). Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J. 17, 2154-2156.
118. Rouzaud, F., Kadekaro, A.L., Abdel-Malek, Z.A., and Hearing, V.J. (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133-152.
119. Sabatier, N., Caquineau, C., Dayanithi, G., Bull, P., Douglas, A.J., Guan, X.M., Jiang, M., Van der Ploeg, L., and Leng, G. (2003). Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J. Neurosci. 23, 10351-10358.
120. Sakai, C., Ollmann, M., Kobayashi, T., Abdel-Malek, Z., Muller, J., Vieira, W.D., Imokawa, G., Barsh, G.S., and Hearing, V.J. (1997). Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J. 16, 3544-3552.
121. Salazar-Onfray, F., Lopez, M., Lundqvist, A. et al. (2002). Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br. J. Cancer 87, 414-422.
122. Sanchez, M.J., Olivares, S.C., Ghanem, G., Haycock, J., Lozano Teruel, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2002). Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur. J. Biochem. 269, 6133-6141.
123. Sanchez Mas, J., Gerritsen, I., Hahmann, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2003). Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res. 16, 540-547.
124. Sanchez-Laorden, B.L., Sanchez-Mas, J., Martínez-Alonso, E., Martínez-Menárguez, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2005a). Dimerization of the human melanocortin 1 receptor. Functional consequences and dominant-negative effects. J. Invest. Dermatol. (in press).
125. Sanchez-Laorden, B.L., Sanchez-Mas, J., Turpin, M.C., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2005b). Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Mol. Cell. Biol. (in press).
126. Sanchez-Mas, J., Hahmann, C., Gerritsen, I., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2004). Agonist-independent, high constitutive activity of the human melanocortin 1 receptor. Pigment Cell Res. 17, 386-395.
127. Sanchez-Mas, J., Guillo, L.A., Zanna, P., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005a). Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol. Endocrinol. 19, 1035-1048.
128. Sanchez-Mas, J., Sanchez-Laorden, B.L., Guillo, L.A., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005b). The melanocortin-1 receptor carboxyl terminal pentapeptide is essential for MC1R function and expression on the cell surface. Peptides 26, 1848-1857.
129. Schiller, M., Brzoska, T., Bohm, M., Metze, D., Scholzen, T.E., Rougier, A., and Luger, T.A. (2004). Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo. J. Invest. Dermatol. 122, 468-476.
130. Schioth, H.B., Petersson, S., Muceniece, R., Szardenings, M., and Wikberg, J.E. (1997). Deletions of the N-terminal regions of the human melanocortin receptors. FEBS Lett. 410, 223-228.
131. Schioth, H.B., Phillips, S.R., Rudzish, R., Birch-Machin, M.A., Wikberg, J.E., and Rees, J.L. (1999). Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem. Biophys. Res. Commun. 260, 488-491.
132. Schioth, H.B., Haitina, T., Ling, M.K., Ringholm, A., Fredriksson, R., Cerda-Reverter, J.M., and Klovins, J. (2005). Evolutionary conservation of the structural, pharmacological, and genomic characteristics of the melanocortin receptor subtypes. Peptides 26, 1886-1900.
133. Schulein, R., Hermosilla, R., Oksche, A., Dehe, M., Wiesner, B., Krause, G., and Rosenthal, W. (1998). A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells. Mol. Pharmacol. 54, 525-535.
134. Scott, M.C., Suzuki, I., and Abdel-Malek, Z.A. (2002a). Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res. 15, 433-439.
135. Scott, M.C., Wakamatsu, K., Ito, S. et al. (2002b). Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 2349-2355.
136. Searle, A.G. (1968). An extension series in the mouse. J. Hered. 59, 341-342.
137. Seifert, R., and Wenzel-Seifert, K. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366, 381-416.
138. Shinyama, H., Masuzaki, H., Fang, H., and Flier, J.S. (2003). Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144, 1301-1314.
139. Siegrist, W., and Eberle, A.N. (1993). Homologous regulation of the MSH receptor in melanoma cells. J. Recept. Res. 13, 263-281.
140. Siegrist, W., Solca, F., Stutz, S., Giuffre, L., Carrel, S., Girard, J., and Eberle, A.N. (1989). Characterization of receptors for alpha-melanocyte- stimulating hormone on human melanoma cells. Cancer Res. 49, 6352-6358.
141. Siegrist, W., Stutz, S., and Eberle, A.N. (1994). Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 54, 2604-2610.
142. Siegrist, W., Willard, D.H., Wilkison, W.O., and Eberle, A.N. (1996). Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors. Biochem. Biophys. Res. Commun. 218, 171-175.
143. Siegrist, W., Drozdz, R., Cotti, R., Willard, D.H., Wilkison, W.O., and Eberle, A.N. (1997). Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J. Recept. Signal Transduct. Res. 17, 75-98.
144. Siracusa, L.D. (1994). The agouti gene: turned on to yellow. Trends Genet. 10, 423-428.
145. Slominski, A. (1998). Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp. Dermatol. 7, 213-216.
146. Slominski, A., Paus, R., and Wortsman, J. (1993). On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 93, C1-C6.
147. Smith, R., Healy, E., Siddiqui, S. et al. (1998). Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111, 119-122.
148. Smith, A.G., Box, N.F., Marks, L.H., Chen, W., Smit, D.J., Wyeth, J.R., Huttley, G.A., Easteal, S., and Sturm, R.A. (2001). The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene 281, 81-94.
149. Solca, F., Siegrist, W., Drozdz, R., Girard, J., and Eberle, A.N. (1989). The receptor for alpha-melanotropin of mouse and human melanoma cells. Application of a potent alpha-melanotropin photoaffinity label. J. Biol. Chem. 264, 14277-14281.
150. Starowicz, K., and Przewlocka, B. (2003). The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 73, 823-847.
151. Strader, C.D., Fong, T.M., Tota, M.R., Underwood, D., and Dixon, R.A. (1994). Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
152. Sturm, R.A. (2002). Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 12, 405-416.
153. Sturm, R.A., Duffy, D.L., Box, N.F., Newton, R.A., Shepherd, A.G., Chen, W., Marks, L.H., Leonard, J.H., and Martin, N.G. (2003). Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann. N. Y. Acad. Sci. 994, 348-358.
154. Subramaniam, S., and Henderson, R. (1999). Electron crystallography of bacteriorhodopsin with millisecond time resolution. J. Struct. Biol. 128, 19-25.
155. Suzuki, I., Tada, A., Ollmann, M.M., Barsh, G.S., Im, S., Lamoreux, M.L., Hearing, V.J., Nordlund, J.J., and Abdel-Malek, Z.A. (1997). Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J. Invest. Dermatol. 108, 838-842.
156. Tan, C.P., McKee, K.K., Weinberg, D.H., MacNeil, T., Palyha, O.C., Feighner, S.D., Hreniuk, D.L., Van Der Ploeg, L.H., MacNeil, D.J., and Howard, A.D. (1999). Molecular analysis of a new splice variant of the human melanocortin-1 receptor. FEBS Lett. 451, 137-141.
157. Tarnow, P., Schoneberg, T., Krude, H., Gruters, A., and Biebermann, H. (2003). Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. J. Biol. Chem. 278, 48666-48673.
158. Vage, D.I., Lu, D., Klungland, H., Lien, S., Adalsteinsson, S., and Cone, R.D. (1997). A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat. Genet. 15, 311-315.
159. Valverde, P., Healy, E., Jackson, I., Rees, J.L., and Thody, A.J. (1995). Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328-330.
160. Vance, K.W., and Coding, C.R. (2004). The transcription network regulating melanocyte development and melanoma. Pigment Cell Res. 17, 318-325.
161. VanLeeuwen, D., Steffey, M.E., Donahue, C., Ho, G., and MacKenzie, R.G. (2003). Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316/317. J. Biol. Chem. 278, 15935-15940.
162. Varga, J.M., Moellmann, G., Fritsch, P., Godawska, E., and Lerner, A.B. (1976). Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells. Proc. Natl Acad. Sci. USA 73, 559-562.
163. Voisey, J., and Van Daal, A. (2002). Agouti: from mouse to man, from skin to fat. Pigment Cell Res. 15, 10-18.
164. Wachira, S.J., Hughes-Darden, C.A., Taylor, C.V., Ochillo, R., and Robinson, T.J. (2003). Evidence for the interaction of protein kinase C and melanocortin 3-receptor signaling pathways. Neuropeptides 37, 201-210.
165. Wakamatsu, K., Graham, A., Cook, D., and Thody, A.J. (1997). Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res. 10, 288-297.
166. Wallin, E., and von Heijne, G. (1995). Properties of N-terminal tails in G-protein coupled receptors: a statistical study. Protein Eng. 8, 693-698.
167. Willard, D.H., Bodnar, W., Harris, C. et al. (1995). Agouti structure and function: characterization of a potent alpha-melanocyte stimulating hormone receptor antagonist. Biochemistry 34, 12341-12346.
168. Wilson, B.D., Ollmann, M.M., Kang, L., Stoffel, M., Bell, G.I., and Barsh, G.S. (1995). Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Genet. 4, 223-230.
169. Wong, W., and Minchin, R.F. (1996). Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells. Int. J. Biochem. Cell Biol. 28, 1223-1232.
170. Wong, T.H., and Rees, J.L. (2005). The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26, 1965-1971.
171. Yang, Y., Dickinson, C., Haskell-Luevano, C., and Gantz, I. (1997a). Molecular basis for the interaction of [Nle4, D-Phe7] melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 272, 23000-23010.
172. Yang, Y.K., Ollmann, M.M., Wilson, B.D., Dickinson, C., Yamada, T., Barsh, G.S., and Gantz, I. (1997b). Effects of recombinant agouti-signaling protein on melanocortin action. Mol. Endocrinol. 11 274-280.